[ad_1]
Health-care firms fell as merchants hedged their bets on the outlook for progress within the sector.
Reckitt Benckiser misplaced virtually $7 billion in market worth after a jury in an Illinois court docket sided with a plaintiff in a case referring to its Enfamil toddler formulation.
Novo Nordisk shares retreated and the fast-growing Danish weight problems drug maker completed the week within the crimson, although its shares have appreciated by greater than 6.5% within the final 30 days alone.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
March 15, 2024 17:56 ET (21:56 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
[adinserter block=”4″]
[ad_2]
Source link